| Year |
Citation |
Score |
| 2023 |
Shapiro MB, Boucher J, Brousseau A, Dehkharghani A, Gabriel J, Kamat V, Patil K, Gao F, Walker J, Kelly R, Souders CA. Alpaca single B cell interrogation and heavy-chain-only antibody discovery on an optofluidic platform. Antibody Therapeutics. 6: 211-223. PMID 37680350 DOI: 10.1093/abt/tbad018 |
0.349 |
|
| 2022 |
Aykul S, Huang L, Wang L, Das NM, Reisman S, Ray Y, Zhang Q, Rothman NJ, Nannuru KC, Kamat V, Brydges S, Troncone L, Johnsen L, Yu PB, Fazio S, et al. ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1. The Journal of Clinical Investigation. PMID 35511419 DOI: 10.1172/JCI153792 |
0.434 |
|
| 2021 |
Kamat V, Boutot C, Rafique A, Granados C, Wang J, Badithe A, Torres M, Chatterjee I, Olsen O, Olson W, Huang T. High affinity human Fc specific monoclonal antibodies for capture kinetic analyses of antibody-antigen interactions. Analytical Biochemistry. 114455. PMID 34788604 DOI: 10.1016/j.ab.2021.114455 |
0.496 |
|
| 2021 |
Gevaert P, De Craemer J, De Ruyck N, Rottey S, de Hoon J, Hellings PW, Volckaert B, Lesneuck K, Orengo JM, Atanasio A, Kamal MA, Abdallah H, Kamat V, Dingman R, DeVeaux M, et al. Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a Phase 1 study. The Journal of Allergy and Clinical Immunology. PMID 34126156 DOI: 10.1016/j.jaci.2021.05.039 |
0.337 |
|
| 2021 |
Atanasio A, Franklin MC, Kamat V, Hernandez AR, Badithe A, Ben LH, Jones J, Bautista J, Yancopoulos GD, Olson W, Murphy AJ, Sleeman MA, Orengo JM. Targeting immunodominant Bet v 1 epitopes with monoclonal antibodies prevents the birch allergic response. The Journal of Allergy and Clinical Immunology. PMID 34126155 DOI: 10.1016/j.jaci.2021.05.038 |
0.4 |
|
| 2020 |
Waite JC, Wang B, Haber L, Hermann A, Ullman E, Ye X, Dudgeon D, Slim R, Ajithdoss DK, Godin SJ, Ramos I, Wu Q, Oswald E, Poon P, Golubov J, ... ... Kamat V, et al. Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy. Science Translational Medicine. 12. PMID 32581132 DOI: 10.1126/Scitranslmed.Aba2325 |
0.352 |
|
| 2020 |
Latuszek A, Liu Y, Olsen O, Foster R, Cao M, Lovric I, Yuan M, Liu N, Chen H, Zhang Q, Xiao H, Springer C, Ehrlich G, Kamat V, Rafique A, et al. Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5. Plos One. 15: e0231892. PMID 32384086 DOI: 10.1371/Journal.Pone.0231892 |
0.444 |
|
| 2020 |
Kamat V, Rafique A, Huang T, Olsen O, Olson W. The impact of different human IgG capture molecules on the kinetics analysis of antibody-antigen interaction. Analytical Biochemistry. 593: 113580. PMID 31926892 DOI: 10.1016/J.Ab.2020.113580 |
0.491 |
|
| 2020 |
Atanasio A, Franklin M, Ben L, Badithe A, Bautista J, Kamat V, Hernandez AR, Olson W, Murphy A, sleeman m, Orengo J. Targeting birch allergy with monoclonal IgG antibodies that bind allergen and prevent IgE effector cell activation Journal of Allergy and Clinical Immunology. 145: AB62. DOI: 10.1016/J.Jaci.2019.12.719 |
0.506 |
|
| 2018 |
Orengo JM, Radin AR, Kamat V, Badithe A, Ben LH, Bennett BL, Zhong S, Birchard D, Limnander A, Rafique A, Bautista J, Kostic A, Newell D, Duan X, Franklin MC, et al. Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement. Nature Communications. 9: 1421. PMID 29650949 DOI: 10.1038/S41467-018-03636-8 |
0.465 |
|
| 2017 |
Kamat V, Rafique A. Designing binding kinetic assay on the bio-layer interferometry (BLI) biosensor to characterize antibody-antigen interactions Analytical Biochemistry. 536: 16-31. PMID 28802648 DOI: 10.1016/J.Ab.2017.08.002 |
0.487 |
|
| 2017 |
Kamat V, Rafique A. Extending the throughput of Biacore 4000 biosensor to accelerate kinetic analysis of antibody-antigen interaction Analytical Biochemistry. 530: 75-86. PMID 28465032 DOI: 10.1016/J.Ab.2017.04.020 |
0.462 |
|
| 2017 |
Kamat V, Rafique A. Exploring sensitivity & throughput of a parallel flow SPRi biosensor for characterization of antibody-antigen interaction Analytical Biochemistry. 525: 8-22. PMID 28223164 DOI: 10.1016/J.Ab.2017.02.007 |
0.483 |
|
| 2017 |
Gusarova V, Banfi S, Alexa-Braun CA, Shihanian LM, Mintah IJ, Lee JS, Xin Y, Su Q, Kamat V, Cohen JC, Hobbs HH, Zambrowicz B, Yancopoulos GD, Murphy AJ, Gromada J. ANGPTL8 Blockade With a Monoclonal Antibody Promotes Triglyceride Clearance, Energy Expenditure and Weight Loss in Mice. Endocrinology. PMID 28204173 DOI: 10.1210/En.2016-1894 |
0.372 |
|
| 2015 |
Pascal KE, Coleman CM, Mujica AO, Kamat V, Badithe A, Fairhurst J, Hunt C, Strein J, Berrebi A, Sisk JM, Matthews KL, Babb R, Chen G, Lai KV, Huang TT, et al. Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proceedings of the National Academy of Sciences of the United States of America. PMID 26124093 DOI: 10.1073/Pnas.1510830112 |
0.403 |
|
| 2008 |
Kamat V, Donaldson JM, Kari C, Quadros MR, Lelkes PI, Chaiken I, Cocklin S, Williams JC, Papazoglou E, Rodeck U. Enhanced EGFR inhibition and distinct epitope recognition by EGFR antagonistic mAbs C225 and 425. Cancer Biology & Therapy. 7: 726-33. PMID 18424917 DOI: 10.4161/Cbt.7.5.6097 |
0.426 |
|
| Show low-probability matches. |